The exosome journey: from biogenesis to uptake and intracellular signalling.

Gurung S, Perocheau D, Touramanidou L, Baruteau J. · 2021

Read The exosome journey: from biogenesis to uptake and intracellular signalling. by Gurung S, Perocheau D, Touramanidou L, Baruteau J. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8063428.txt.

Introduction

Gurung and co-authors trace the full journey of an exosome, from birth inside a cell to action in the next. Exosomes are small vesicles that all cells release. They carry proteins, metabolites, and nucleic acids between cells. Trials now test them as diagnostics and as drug carriers. Sound clinical use demands a clear grip on their biology.

The review maps each step of the journey in turn. Pathways of biogenesis and secretion come first. Transport and uptake by recipient cells follow. The authors then explain the signaling the cargo triggers inside. Disputes get plain treatment as well. Even the definition and naming of exosomes remain contested. Common pitfalls that trip up new studies are flagged. The result is a field guide for careful exosome work.

Catalog record

CREATORGurung S, Perocheau D, Touramanidou L, Baruteau J.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE90 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8063428

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The exosome journey: from biogenesis to uptake and intracellular signalling By Sonam Gurung, Dany Perocheau, Loukia Touramanidou, Julien Baruteau Published in: Cell Communication and Signaling : CCS DOI: 10.1186/s12964-021-00730-1 ABSTRACT The use of exosomes in clinical settings is progressively becoming a reality, as clinical trials testing exosomes for diagnostic and therapeutic applications are generating remarkable interest from the scientific community and investors. Exosomes are small extracellular vesicles secreted by all cell types playing intercellular communication roles in health and disease by transferring cellular cargoes such as functional proteins, metabolites and nucleic acids to recipient cells. An in-depth understanding of exosome biology is therefore essential to ensure clinical development of exosome based investigational therapeutic products. Here we summarise the most up-to-date knowkedge about the complex biological journey of exosomes from biogenesis and secretion, transport and uptake to their intracellular signalling. We delineate the major pathways and molecular players that influence each step of exosome physiology, highlighting the routes of interest, which will be of benefit to exosome manipulation and engineering. We highlight the main controversies in the field of exosome research: their adequate definition, characterisation and biogenesis at plasma membrane. We also delineate the most common identified pitfalls affecting exosome research and development. Unravelling exosome physiology is key to their ultimate progression towards clinical applications. Video Abstract Supplementary Information The online version contains supplementary material available at 10.1186/s12964-021-00730-1. BACKGROUND Extracellular vesicles (EVs) are released by all cells, prokaryotes and eukaryotes, and regulate intercellular communication in health and disease [1, 2]. Exosomes are a subset of EVs that were initially identified as a cellular mechanism to excrete unwanted cellular products [3]. They are now known to play significant roles in cellular communication by transferring functional proteins, metabolites and nucleic acids to recipient cells [4–6]. They influence a broad range of physiological processes such as immune responses [7], tissue repair [8, 9], stem cell maintenance [10], central nervous system (CNS) communication [6] and pathological processes in cardiovascular diseases [11, 12], neurodegeneration [13], cancer [14] and inflammation [15]. Exosomes have generated considerable interest for clinical application as diagnostic biomarkers and therapeutic cargo carriers [16]. Reduced immunogenicity due to their biocompatibility and a bi-layered lipid structure, which protects the genetic cargo from degradation, makes them attractive as therapeutic vectors. Their small size and membrane composition allow them to cross major biological membranes including the blood brain barrier. Production of engineered exosomes is an active research field, which fosters assessment of various therapeutic cargoes, enhancement of target selectivity and optimisation of manufacturing [17, 18]. A major limitation for successful translation remains the difficulty to precisely target the cell type or organ of interest whilst limiting off-target biodistribution. Another concern is the presence of naturally incorporated cellular genetic impurities with potential immunogenicity [18–20]. To circumvent these difficulties, a better understanding of exosome biology in order to improve therapeutic exosome engineering is key. In this review, we present the most up-to-date knowledge of exosome biology detailing their biogenesis and secretion mechanisms, targeting of recipient cell, uptake and intracellular signalling. Although we acknowledge the complexity of multiple biological mechanisms for secretion and uptake, we highlight the main mechanisms, which could be relevant to exosome engineering for therapeutic applications. We address as well current controversies and common pitfalls impeding exosome research. EV CLASSIFICATION Extracellular vesicles (EVs) are classified into three groups typically based on their size and biogenesis: exosomes (30–200 nm), microvesicles (MVs) (100–1000 nm) and apoptotic bodies (> 1000 nm) [5, 21–24] (Fig. 1). Exosomes are considered to be of endocytic origin, MVs are produced by budding and blebbing from the plasma membrane and apoptotic bodies are released by cells undergoing programmed cell death and signal cell engulfment [25]. EVs are further differentiated based on their density, composition and function [25, 26] (Table 1). While all EVs have complex composition of proteins, nucleic acids, lipids and metabolites (Table 1, Fig. 1), sizes and marker overlaps between heterogeneous EVs can make their differentiation harder [2, 27]. In this review, the exosome terminology is used if clarified in the referenced publication and the term EV is used if the differentiation is unclear.Fig. 1Extracellular vesicles (EVs) classification. The three different classes of EVs are depicted. a Exosomes are generated through the endocytic pathway and are released via exocytosis, are spherical in shape and have size range of 30–200 nm of diameter. b Microvesicles (MVs) are released through budding from plasma membrane, are irregular in shape and range in size between 100–1000 nm of diameter. c Apoptotic bodies are released through blebbing by cells undergoing apoptosis and are > 1000 nm in sizeTable 1Extravesicles subtype characteristicsExosomesMicrovesiclesApoptotic bodiesOriginEndocytic originPlasma membrane buddingBlebbingSize30–200 nm100–1000 nm > 1000 nmDensity1.13–1.19 g/ml1.04–1.07 g/ml1.16–1.28 g/mlShapeSpheroidIrregularVariableCompositionProteins, nucleic acids, lipids and metabolitesProteins, nucleic acids, lipids and metabolitesDNA fragments and histone, chromatin remnants, cytosol portions, degraded proteinsTypical constituent proteinsTetraspanins, ESCRT proteins (Alix, TSG101), integrins, heat shock proteinsIntegrins, selectins, CD40 ligand, flotillin-2, adenosine diphosphate ribosylation factor 6, phosphatidylserineAnnexin V, phosphatidylserineFunctionCell–cell communicationCell–cell communicationProduct of programmed cell death. Facilitate clearance of apoptotic cellsReferences[21, 25, 28, 185, 186][5, 21, 22, 25, 185, 186][21, 23–26] BIOLOGICAL COMPOSITION OF EXOSOMES Exosomes are membrane bound carriers. Their cargoes can include proteins, nucleic acids and metabolites (Fig. 2) [28], reflecting the nature of donor cell and its physiological state [12]. Exosomes have a spheroid shape in solution but appear bi-concave or cup-shaped when produced by artificial drying during preparation [29]. The main membrane bound and cytosolic proteins incorporated in exosomes are members of the tetraspanin family (CD9, CD63 and CD81), endosomal sorting complex required for transport (ESCRT) proteins (Alix, TSG101), integrins, heat shock proteins (Hsp), actin and flotillins [16, 30] (Table 2). While proteins such as heat shock proteins, CD63, ESCRT and cytoskeletal components are common among all exosomes, other proteins such as MHC Class I and II are specific to the donor cell type [31]. The rigid bilayer membrane of exosomes also consist of lipid components such as sphingomyelin, cholesterol and ceramides, which influence cargo sorting, exosome secretion, structure and signalling [32, 33] (Table 2). A complex of nucleic acids such as DNA, mRNA and noncoding RNA species as well form part of the exosome composition [2, 31]. MicroRNAs (miRs) are one of the most abundant RNA species in exosomes [16, 34]. MiRs, which play roles in multiple biological processes such as exocytosis, hematopoesis and angiogenesis, participate in exosome mediated cellular communication [16]. Other exosomal RNA species include ribosomal RNA (rRNA), long non-coding RNA (lncRNA), transfer RNA (tRNA), small nuclear RNA (snRNA), small nucleolar RNA and p-element-induced wimpy testis (piwi)-interacting RNA, all of which impact biological processes, particularly influencing tumor development [16, 35]. Studies have thus explored their potential for use as non-invasive disease diagnostic and prognostic tool.Fig. 2Composition of exosomes. Exosomes are composed of various proteins: transmembrane proteins such as tetraspanins, antigen presenting molecules, glycoproteins and adhesion molecules; proteins in exosome lumen such as heat shock proteins (Hsp), cytoskeletal proteins, ESCRT components, membrane transport, fusion proteins, growth factors and cytokines. Exosomes also comprise of multiple lipids such as cholesterol, ceramides, sphingomyelin, phosphatidylinostol (PI), phosphatidylserine (PS), phosphatidylcholine (PC), phosphatidylethanolamine (PE) and gangliosides (GM) along with nucleic acids such as mRNA, miRNA, non-coding RNA and DNA in their lumen. Hsc = Heat shock cognate; TSG = tumor suspectibility gene; TNF =

Read the complete text